|
PDE7A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.37860000002122E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.767800E-04 |
| Normal-vs-Stage2 |
1.829830E-04 |
| Normal-vs-Stage3 |
1.595390E-03 |
| Normal-vs-Stage4 |
9.938400E-02 |
| Stage1-vs-Stage2 |
1.203950E-01 |
| Stage1-vs-Stage3 |
4.689800E-01 |
| Stage1-vs-Stage4 |
3.869400E-01 |
| Stage2-vs-Stage3 |
3.579200E-01 |
| Stage2-vs-Stage4 |
8.589400E-01 |
| Stage3-vs-Stage4 |
7.558800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.57751999999567E-05 |
| Normal-vs-AfricanAmerican |
1.082120E-03 |
| Normal-vs-Asian |
1.627960E-01 |
| Caucasian-vs-AfricanAmerican |
6.584200E-01 |
| Caucasian-vs-Asian |
6.555800E-01 |
| AfricanAmerican-vs-Asian |
7.397800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.95719999999922E-05 |
| Normal-vs-Female |
3.41349999999352E-06 |
| Male-vs-Female |
4.520200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.105960E-02 |
| Normal-vs-Extreme_Weight |
9.581100E-03 |
| Normal-vs-Obese |
1.026920E-04 |
| Normal-vs-Extreme_Obese |
7.501800E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.989000E-01 |
| Normal_Weight-vs-Obese |
2.263200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.823000E-01 |
| Extreme_Weight-vs-Obese |
2.643900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.089400E-01 |
| Obese-vs-Extreme_Obese |
3.493800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.944800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.79769999997248E-06 |
| Normal-vs-Age(61-80Yrs) |
1.595320E-03 |
| Normal-vs-Age(81-100Yrs) |
3.018000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.293800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.689900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.085200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.912100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.346000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.106800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.158300E-04 |
| Normal-VS-Type2 PRCC |
9.80689999999784E-05 |
| Normal-VS-KIRP CIMP |
2.472200E-02 |
| Normal-VS-Unclassified PRCC |
2.150900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.268780E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.401780E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.330100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.887600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.633770E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.495200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.299830E-03 |
| Normal-vs-N1 |
2.575700E-04 |
| Normal-vs-N2 |
1.551970E-01 |
| N0-vs-N1 |
2.264400E-01 |
| N0-vs-N2 |
7.093000E-01 |
| N1-vs-N2 |
3.189000E-01 |
|
|
